Max Kruziki - Publications
Affiliations: | University of Minnesota, Twin Cities, Minneapolis, MN |
Year | Citation | Score | |||
---|---|---|---|---|---|
2018 | Case BA, Kruziki MA, Stern LA, Hackel BJ. Evaluation of affibody charge modification identified by synthetic consensus design in molecular PET imaging of epidermal growth factor receptor. Molecular Systems Design & Engineering. 3: 171-182. PMID 31467687 DOI: 10.1039/C7ME00095B | 0.737 | |||
2018 | Du F, Kruziki MA, Zudock EJ, Zhang Y, Lown PS, Hackel BJ. Engineering an EGFR-Binding Gp2 Domain for Increased Hydrophilicity. Biotechnology and Bioengineering. PMID 30536855 DOI: 10.1002/bit.26893 | 0.744 | |||
2018 | Kruziki MA, Sarma V, Hackel BJ. Constrained combinatorial libraries of Gp2 proteins enhance discovery of PD-L1 binders. Acs Combinatorial Science. PMID 29799714 DOI: 10.1021/acscombsci.8b00010 | 0.736 | |||
2018 | Case BA, Kruziki MA, Johnson SM, Hackel BJ. Engineered charge redistribution of Gp2 proteins through guided diversity for improved PET imaging of epidermal growth factor receptor. Bioconjugate Chemistry. PMID 29579383 DOI: 10.1021/acs.bioconjchem.8b00144 | 0.717 | |||
2017 | Senkow TL, Woldring DR, Kruziki M, Hackel BJ, Sachs JN. Evaluation of High Affinity Scaffolds from High-Throughput Discovery and Targeting DR5 and TNFR1 Biophysical Journal. 112: 530a. DOI: 10.1016/J.Bpj.2016.11.2865 | 0.716 | |||
2016 | Kruziki MA, Case BA, Chan JY, Zudock EJ, Woldring DR, Yee D, Hackel BJ. A 64Cu-labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor. Molecular Pharmaceutics. PMID 27696863 DOI: 10.1021/Acs.Molpharmaceut.6B00538 | 0.658 | |||
2015 | Kruziki MA, Bhatnagar S, Woldring DR, Duong VT, Hackel BJ. A 45-Amino-Acid Scaffold Mined from the PDB for High-Affinity Ligand Engineering. Chemistry & Biology. 22: 946-56. PMID 26165154 DOI: 10.1016/j.chembiol.2015.06.012 | 0.783 | |||
Show low-probability matches. |